http://www.amicusrx.com
Amicus Therapeutics, Inc. Company Intro
Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.
Industry
Healthcare
Amicus Therapeutics, Inc. Headquaters
1 Cedar Brook Drive
Cranbury,08512
United States
Amicus Therapeutics, Inc. Share price
14 Sep 2022 09:15 GMT
$11.12
-0.22 (-1.94 %)
Amicus Therapeutics, Inc. Market cap
$2.94 B
WMC RANKING
2023
Amicus Therapeutics, Inc. # 39
BiotechnologyLatest Amicus Therapeutics, Inc. News
27 Jan 2023
Global Neurometabolic Disorders Market: Market Players ...
Global Neurometabolic Disorders Market: Market Players ...
27 Jan 2023
Boiling and ready to burst as Amicus Therapeutics Inc. (FOLD ...
Amicus Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company's stock is recorded $13.61 on...
27 Jan 2023
LATAM Fabry Disease Market report covers future trends with ...
Amicus Therapeutics, Inc., Sanofi-Aventis U.S. LLC, GlaxoSmithKline plc, Mendelics, Takeda Pharmaceuticals U.S.A., Inc, Teva pharmaceutical Industries Ltd,...
WMC Market Score
WMC Market to Revenue Score
Amicus Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Amicus Therapeutics, Inc. | USD | $266,763 | $455,044 | $-253,568 | $29,400B | 39 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Amicus Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Amicus Therapeutics, Inc. Post vs Top 4 Industry Competitors
Amicus Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Amicus Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Amicus Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Amicus Therapeutics, Inc. | 2.90 | 13.30 | 0.04 | 0 | 0 | 0 | 6.01 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
